Stanford scientists spy 15 new coronary disease markers; Abbott gains FDA nod for new testicular cancer Dx;

> Researchers at the Stanford University School of Medicine and their colleagues have identified 15 new genetic regions associated with coronary artery disease. Blog

> EMD Millipore has debuted genomic biomarker services, an initiative that comes as the U.S. market for personalized medicine is poised to explode. Item

> The metabolic profile of an organism is a good indicator of its level of cellular aging and the overall health of a mouse, researchers at the Spanish National Cancer Research Centre and others have determined. Item

> Biocartis in Switzerland recently debuted a new biomarker analysis system designed to process data on several biomarkers at the same time. Release

> Boston Children's Hospital won a new $1.7 million grant to pursue research identifying and validating biomarkers of gut function in infants and young children in the developing world. Item

> Abbott ($ABT) has FDA approval for a new molecular diagnostic blood test to help determine if a testicular cancer is progressing or whether a fetus has a particular kind of birth defect. FDA announcement

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.